# Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 in Japanese and Chinese Healthy Volunteers..

> **NCT05955183** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 38 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** AZD5055
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05955183
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-27
- **Primary completion:** 2023-12-04
- **Final completion:** 2023-12-04
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2023-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05955183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05955183, "Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 in Japanese and Chinese Healthy Volunteers..". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05955183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*